Literature DB >> 3203064

Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing.

S H Jackson1, A Johnston, R Woollard, S M Abrams, P Turner.   

Abstract

1. Eight volunteers were given seven doses of 200 mg of slow release theophylline at either 11.00 h and 23.00 h (regimen 1) or 17.00 h and 05.00 h (regimen 2). At the time of the sixth dose (60 h) hourly blood sampling was started and continued for 24 h. After at least 1 week volunteers crossed over to the other regimen. 2. Volunteers retired to bed at 23.00 h and arose after the 07.00 h sample during both regimens. 3. During regimen 1 there was a marked rise in mean tmax from 3.3 h after dosing at 11.00 h to 9.3 h after dosing at 23.00 h (P less than 0.001). There was also a fall in AUC(0,12) from 89.9 mg l-1 h after dosing at 11.00 h to 79.0 mg l-1 h after dosing at 23.00 h. There was no difference in mean Cmax values. 4. During regimen 2 these circadian changes were abolished with mean values after both dosing times lying between those observed during regimen 1. 5. A marked delay in absorption occurs at night and cannot be explained by food intake.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203064      PMCID: PMC1386502          DOI: 10.1111/j.1365-2125.1988.tb03366.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Theophylline concentrations and posture.

Authors:  J Warren
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

2.  Asthma at night.

Authors:  W R Primrose
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

3.  Investigation of diurnal changes in the disposition of theophylline.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

4.  Chronopharmacology of amitriptyline.

Authors:  S Nakano; L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

5.  Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.

Authors:  N H Leeds; P Gal; A A Purohit; J B Walter
Journal:  J Clin Pharmacol       Date:  1982-04       Impact factor: 3.126

6.  Homogeneous enzyme immunoassay for theophylline in serum and plasma.

Authors:  J Chang; S Gotcher; J B Gushaw
Journal:  Clin Chem       Date:  1982-02       Impact factor: 8.327

7.  Circadian acrophases of human 17-hydroxycorticosteroid excretion referred to midsleep rather than midnight.

Authors:  F Halberg; H Simpson
Journal:  Hum Biol       Date:  1967-12       Impact factor: 0.553

8.  Food induced changes in theophylline absorption from a once-a-day theophylline product.

Authors:  G Steffensen; S Pedersen
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

9.  Food does not effect in bioavailability of theophylline from Theolin Retard.

Authors:  A P Sips; P M Edelbroek; S Kulstad; F A de Wolff; J H Dijkman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.

Authors:  K P Coulthard; D J Birkett; D R Lines; N Grgurinovich; J J Grygiel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  3 in total

1.  Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline.

Authors:  W Couet; I Ingrand; B Reigner; J Girault; J Bizouard; J B Fourtillan
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 3.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.